STOCK TITAN

Fold Holdings (Nasdaq: FLD) pulls credit facility release, says no agreement

(Neutral)
(Neutral)
Form Type
424B3

Rhea-AI Filing Summary

Fold Holdings, Inc. registers up to 9,282,287 shares of Common Stock. This prospectus supplement, dated May 27, 2026, updates the Prospectus dated August 11, 2025 and attaches a Current Report clarifying that a May 27 press release about a credit facility was retracted and that no credit facility has been entered into as of the date hereof.

The supplement states the company’s last reported sales price was $1.025 per share of Common Stock and $0.1199 per Warrant on May 26, 2026. The supplement amends the Prospectus and should be read together with it.

Positive

  • None.

Negative

  • None.

Insights

Registers up to 9,282,287 shares; supplement corrects a retracted press release.

The supplement amends the Prospectus dated August 11, 2025 to include a Current Report clarifying that a press release claiming a credit facility was published and then retracted; the Company states it has not entered such a facility as of May 27, 2026.

Legal dependencies include the registration statement on Form S-1 (No. 333-288623) and incorporation by reference mechanics; any issuance under the registration will need to follow the Prospectus distribution terms and disclosure obligations.

Registration creates capacity for up to 9,282,287 shares of common stock.

The prospectus supplement lists 9,282,287 shares as the maximum registered amount and repeats the last reported trading prices for common stock and warrants on May 26, 2026. The filing does not state pricing, recipient of proceeds, or planned sale methods.

Markets will await a separate disclosure for any planned issuance mechanics, pricing, or intended use of proceeds; timing and proceeds treatment are not provided in this excerpt.

Registered shares 9,282,287 shares Prospectus Supplement dated May 27, 2026
Last reported stock price $1.025 Common Stock last reported sales price on May 26, 2026
Last reported warrant price $0.1199 Warrant last reported sales price on May 26, 2026
prospectus supplement regulatory
"This prospectus supplement updates, amends and supplements the prospectus dated August 11, 2025"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
registration statement on Form S-1 regulatory
"forms a part of our registration statement on Form S-1 (No. 333-288623)"
A registration statement on Form S-1 is a detailed filing a company submits to the U.S. securities regulator to register new shares for public sale; it includes a plain-language prospectus, financial statements, business description and risk factors. For investors it matters because it provides the official, comprehensive blueprint of the offering — like an owner’s manual — allowing buyers to assess risks, inspect financial health and compare valuation before deciding to invest.
Current Report on Form 8-K regulatory
"information contained in our Current Report on Form 8-K filed with the Securities and Exchange Commission on May 27, 2026"
A current report on Form 8-K is a document that publicly traded companies file to promptly share important news or events that could affect their financial position or stock price, such as major business changes or legal issues. It helps investors stay informed about timely developments, allowing them to make better decisions about buying or selling shares.
Offering Type primary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

 

Filed pursuant to Rule 424(b)(3)

Registration No. 333-288623

PROSPECTUS SUPPLEMENT NO. 17

(to Prospectus dated August 11, 2025)

Fold Holdings, Inc.

Up to 9,282,287 Shares of Common Stock

 

This prospectus supplement updates, amends and supplements the prospectus dated August 11, 2025 (as supplemented or amended from time to time, the “Prospectus”), which forms a part of our registration statement on Form S-1 (No. 333-288623). Capitalized terms used in this prospectus supplement and not otherwise defined herein have the meanings specified in the Prospectus.

 

This prospectus supplement is being filed to update and supplement the information in the Prospectus with the information contained in our Current Report on Form 8-K filed with the Securities and Exchange Commission on May 27, 2026 (the “Current Report”). Accordingly, we have attached the Current Report to this prospectus supplement.

This prospectus supplement updates and supplements the information in the Prospectus and is not complete without, and may not be delivered or utilized except in combination with, the Prospectus, including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the Prospectus and if there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement.

Our Common Stock and Warrants are listed on the Nasdaq Stock Market LLC under the symbols “FLD” and “FLDDW,” respectively. The last reported sales price of our Common Stock and Warrants on the Nasdaq Stock Market LLC on May 26, 2026 were $1.025 per share of Common Stock and $0.1199 per Warrant.

Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 7 of the Prospectus and other risk factors contained in the documents incorporated by reference therein, to read about factors you should consider before buying our securities.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the Prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

The date of this prospectus supplement is May 27, 2026.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 27, 2026

Fold Holdings, Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-41168

86-2170416

(State or other jurisdiction
of incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

- 1 -


 

 

2942 North 24th Street, Suite 115, #42035

Phoenix, Arizona

 

 

85016

(Address of principal executive offices)

(Zip Code)

 

(866) 365-3277

Registrant’s telephone number, including area code

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

Trading Symbol(s)

Name of Each Exchange on Which
Registered

Common stock, par value $0.0001 per share

FLD

Nasdaq Capital Market

Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share

FLDDW

Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

- 2 -


 

Item 7.01 Regulation FD Disclosure.

On May 27, 2026, a press release was published announcing that Fold Holdings, Inc. (the "Company", "we", "our", or "us") had entered into a credit facility with a third party to support its credit card program. That press release has been retracted. The Company wishes to clarify that as of the date hereof, the Company has not entered into any such credit facility. While the Company is always looking for ways to support its credit card program, it cannot guarantee that it will enter into a credit facility for the credit card program with any given third party, or even enter into such a credit facility at all.

 

The information contained in Item 7.01 of this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.

 

 

- 3 -


 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

FOLD HOLDINGS, INC.

By:

/s/ Will Reeves

Name:

Will Reeves

Title:

Chief Executive Officer

Dated: May 27, 2026

- 4 -